Cystic Fibrosis Expanded Screen - CFvantage

The Cystic Fibrosis Expanded Screen - CFvantage test contains 1 test with 5 biomarkers.

The CFvantage® Cystic Fibrosis Expanded Screen analyzes 155 mutations that have been proven to cause Cystic Fibrosis. This panel includes the 23 mutations recommended by the American College of Obstetricians and Gynecologists (ACOG) for screening of all child bearing age women. ACOG also recommends that patients with a family history of Cystic Fibrosis, pregnant women with ultrasound finding that indicate an increased risk of Cystic Fibrosis (echogenic bowel or dilated loops of the bowl), and males with a family history of infertility should be offered this screen.

The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.

Also known as: CFVANTAGE CYSTIC FIBROSIS EXPANDED SCR

ADDITIONAL INFORMATION

CF RESULT

ETHNICITY:

INTERPRETATION

MUTATIONS ANALYZED

*Important Information on Lab Test Processing Times: Ulta Lab Tests is committed to informing you about the processing times for your lab tests processed through Quest Diagnostics. Please note that the estimated processing time for each test, indicated in business days, is based on data from the past 30 days across the 13 Quest Diagnostics laboratories for each test. These estimates are intended to serve as a guide and are not guarantees. Factors such as laboratory workload, weather conditions, holidays, and the need for additional testing or maintenance can influence actual processing times. We aim to offer estimates to help you plan accordingly. Please understand that these times may vary, and processing times are not guaranteed. Thank you for choosing Ulta Lab Tests for your laboratory needs.

Customer Reviews